Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications

J Feng, X Wang, X Ye, I Ares, B Lopez-Torres… - Pharmacological …, 2022 - Elsevier
Metformin is the oldest and most commonly used first-line antidiabetic drug because of its
good clinical efficacy, high safety, low cost and easy access. At the same time, in recent …

Metabolic reprogramming: the emerging concept and associated therapeutic strategies

GJ Yoshida - Journal of experimental & clinical cancer research, 2015 - Springer
Tumor tissue is composed of cancer cells and surrounding stromal cells with diverse
genetic/epigenetic backgrounds, a situation known as intra-tumoral heterogeneity. Cancer …

[HTML][HTML] Therapeutic options for management of endometrial hyperplasia

V Chandra, JJ Kim, DM Benbrook… - Journal of …, 2016 - synapse.koreamed.org
Endometrial hyperplasia (EH) comprises a spectrum of changes in the endometrium ranging
from a slightly disordered pattern that exaggerates the alterations seen in the late …

Activated fibroblast program orchestrates tumor initiation and progression; molecular mechanisms and the associated therapeutic strategies

GJ Yoshida, A Azuma, Y Miura, A Orimo - International Journal of …, 2019 - mdpi.com
Neoplastic epithelial cells coexist in carcinomas with various non-neoplastic stromal cells,
together creating the tumor microenvironment. There is a growing interest in the cross-talk …

Effects of metformin on endometrial cancer: Systematic review and meta-analysis

CG Meireles, SA Pereira, LP Valadares, DF Rêgo… - Gynecologic …, 2017 - Elsevier
Background Endometrial cancer is one of the most common gynecological cancers, which is
frequently preceded by atypical endometrial hyperplasia, a premalignant lesion. Metformin …

The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS …

H Cabrera-Cruz, L Oróstica… - American journal …, 2020 - journals.physiology.org
Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disorder characterized by
hyperandrogenism and ovulatory dysfunction but also obesity and hyperinsulinemia. These …

Metformin intervention—a panacea for cancer treatment?

A Buczyńska, I Sidorkiewicz, AJ Krętowski… - Cancers, 2022 - mdpi.com
Simple Summary This literature analysis is focused on the pleiotropic action associated with
metformin treatment. Precisely, metformin treatment exerts many health effects, mainly by …

Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant reactive oxygen species production

M Hu, Y Zhang, X Guo, W Jia, G Liu… - American Journal …, 2019 - journals.physiology.org
Women with polycystic ovary syndrome (PCOS) are at increased risk of miscarriage, which
often accompanies the hyperandrogenism and insulin resistance seen in these patients …

TLR4-associated IRF-7 and NFκB signaling act as a molecular link between androgen and metformin activities and cytokine synthesis in the PCOS endometrium

M Hu, Y Zhang, X Li, P Cui… - The Journal of …, 2021 - academic.oup.com
Context Low-grade chronic inflammation is commonly seen in polycystic ovary syndrome
(PCOS) patients with elevated levels of inflammatory cytokines in the endometrium …

Metformin use and gynecological cancers: a novel treatment option emerging from drug repositioning

A Gadducci, N Biglia, R Tana, S Cosio… - Critical reviews in oncology …, 2016 - Elsevier
Metformin exerts antitumor effects mainly through AMP-activated protein kinase [AMPK]
activation and phosphatidylinositol 3-kinase [PI3K]-Akt-mammalian target of rapamycin …